Respiratory viruses: New frontiers-a Keystone Symposia report.
Autor: | Cable J; PhD Science Writer, New York, New York, USA., Sun J; Division of Pulmonary and Critical Medicine, Department of Medicine; Department of Immunology; and Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, USA.; Carter Immunology Center and Division of Infectious Disease and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA., Cheon IS; Division of Pulmonary and Critical Medicine, Department of Medicine; Department of Immunology; and Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, USA.; Carter Immunology Center and Division of Infectious Disease and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA., Vaughan AE; University of Pennsylvania School of Veterinary Medicine, Biomedical Sciences, Philadelphia, Pennsylvania, USA., Castro IA; Virology Research Center, Ribeirao Preto Medical School, University of São Paulo - USP, São Paulo, Brazil., Stein SR; Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center and Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., López CB; Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Molecular Microbiology and Center for Women Infectious Disease Research, Washington University School of Medicine, St Louis, Missouri, USA., Gostic KM; Department of Ecology and Evolution, University of Chicago, Chicago, Illinois, USA., Openshaw PJM; Department of Respiratory Medicine, Imperial College London, London, UK., Ellebedy AH; Department of Pathology and Immunology; The Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs; and Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St Louis, Missouri, USA., Wack A; Immunoregulation Laboratory, The Francis Crick Institute, London, UK., Hutchinson E; MRC - University of Glasgow Centre for Virus Research, Glasgow, UK., Thomas MM; Montana State University, Bozeman, Montana, USA., Langlois RA; Center for Immunology and Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, USA., Lingwood D; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA., Baker SF; Lovelace Biomedical Research Institute, Albuquerque, New Mexico, USA., Folkins M; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada., Foxman EF; Department of Laboratory Medicine and Department of Immunology, Yale University School of Medicine, New Haven, Connecticut, USA., Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA., Schwemmle M; Institute of Virology, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Russell AB; Division of Biological Sciences, University of California, San Diego, La Jolla, California, USA., Chiu C; Department of Infectious Disease, Imperial College London, London, UK., Ganti K; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA., Subbarao K; Department of Microbiology and Immunology, WHO Collaborating Centre for Reference and Research on Influenza at the Peter Doherty Institute for Infection and Immunity, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Sheahan TP; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Penaloza-MacMaster P; Department of Microbiology-Immunology, School of Medicine, Northwestern University Feinberg, Chicago, Illinois, USA., Eddens T; Pediatric Scientist Development Program, University of Pittsburgh Medical Center (UPMC) Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2023 Apr; Vol. 1522 (1), pp. 60-73. Date of Electronic Publication: 2023 Feb 01. |
DOI: | 10.1111/nyas.14958 |
Abstrakt: | Respiratory viruses are a common cause of morbidity and mortality around the world. Viruses like influenza, RSV, and most recently SARS-CoV-2 can rapidly spread through a population, causing acute infection and, in vulnerable populations, severe or chronic disease. Developing effective treatment and prevention strategies often becomes a race against ever-evolving viruses that develop resistance, leaving therapy efficacy either short-lived or relevant for specific viral strains. On June 29 to July 2, 2022, researchers met for the Keystone symposium "Respiratory Viruses: New Frontiers." Researchers presented new insights into viral biology and virus-host interactions to understand the mechanisms of disease and identify novel treatment and prevention approaches that are effective, durable, and broad. (© 2023 New York Academy of Sciences.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |